D07001 Softgel-Capsules
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for D07001 Softgel-Capsules, covering 2023-11-24 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer [Phase 3]